Phio Pharmaceuticals Announces Upcoming Presentations at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

(marketscreener.com) MARLBOROUGH, Mass., Oct. 6, 2022 /PRNewswire/ -- Phio Pharmaceuticals Corp. , a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi therapeutic platform, today announced it is scheduled to provide an update on its programs at the 37th Annual Meeting of the Society for...https://www.marketscreener.com/quote/stock/PHIO-PHARMACEUTICALS-CORP-47281669/news/Phio-Pharmaceuticals-Announces-Upcoming-Presentations-at-the-37th-Annual-Meeting-of-the-Society-for-41941549/?utm_medium=RSS&utm_content=20221006